The objective of this study was to assess complex skeletal and metabolic changes in a single cohort of PCa patients taking long-term ADT.
PATIENTS AND METHODS
Ninety-five patients with… (More)
Androgen deprivation therapy (ADT) for prostate cancer (PCa) may increase peripheral insulin resistance, induce type 2 diabetes, change body composition, and alter lipoprotein profile. Some studies… (More)